Pathqa
Digital pathology colour calibration and quality assurance products for scanner manufacturers, labs, and AI developers
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-10
About Pathqa
PathQA develops the Sierra product range for digital pathology quality assurance. Products include stained calibration slides, whole-slide imaging scanner colour validation and reporting, and ICC profiles to standardise image colour.
Its products serve end users, scanner manufacturers, AI and image-management-system developers, and pre-clinical, CRO, and clinical users. PathQA Ltd was founded in 2023 and is headquartered in London, United Kingdom.
Product: Sierra calibration slides and software tools for measuring, reporting, and standardising colour in digital pathology images.
Jobs at Pathqa
Leadership
- Rick Salmon · CEOSource: company website
- Pete Collins · COOSource: company website
More health & medtech companies
patient-services.co.uk
Online GP services letting patients order prescriptions, book appointments and view records with their practice in the UKNew on Evolcpatientcomms.co.uk
Patient engagement software and digital services for dental practices in the UK and EuropeNew on EvolcPatients Know Best
Personal health record platform connecting patients with health and social care providersNew on EvolcPatientsource
Modular cloud electronic patient record software for hospitals, clinics and other healthcare providersNew on EvolcPawsitive Vet Care
Veterinary care for pets and their owners in Hartlebury and surrounding Worcestershire communitiesNew on EvolcPaydens
Pharmacy group running over 100 pharmacies in South-East England, with online NHS prescription ordering and home deliveryNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.